Dr Nabi Shah
Tenured Associate ProfessorArea of Interest: Pharmacology (Pharmacoepidemiology, Pharmacogenetics and Pharmacogenomics)
Email: nabishah@cuiatd.edu.pk
Phone: 0992-383591-6
| Postdoctoral Studies Pat McPherson Center for Pharmacogenomics
& Pharmacogenetics, Medical Research Institute Ninewells Hospital &
Medical School, University of Dundee, UK, 2014-2016 M.Phil/Ph.D Pharmacology, Faculty of
Pharmacy, University of Karachi, Pakistan, 2013 B.Pharmacy Faculty of Pharmacy, University
of Karachi, Pakistan, 2006 |
| Oct 2013-To date Assistant Professor of Pharmacology COMSATS Institute of
Information Technology, Department of Pharmacy, Abbottabad campus, Pakistan
2016-To date Honorary Associate
Staff (Postdoctoral Research Assistant) Pat McPherson Center for Pharmacogenomics & Pharmacogenetics,
Medical Research Institute, Ninewells Hospital & Medical School, University
of Dundee, Scotland, UK 2014-2016 Postdoctoral
Research Assistant Pat McPherson Center for Pharmacogenomics & Pharmacogenetics,
Medical Research Institute, Ninewells Hospital & Medical School, University
of Dundee, Scotland, UK 2009- 2013 Research Officer Center
for Non Communicable Diseases, Karachi (June, 2009-June 2013)
2011-2012 Visiting Scholar Cardiovascular
Epidemiology Unit, Department of Public Health and Primary Care, University of
Cambridge:(October, 2011- March, 2012)
2006-2009 Research Associate Department
of Biological and Biomedical Sciences (DBBS), Aga Khan University Karachi,
Karachi. Pakistan. (September, 2006- May, 2009) |
| I am working on large-scale leading genetic associations’ studies
of South Asia (Pakistan)and European population such as, Pakistan Risk of Myocardial Infarction
Study (PROMIS), Risk Assessment of Cerebrovascular Events
(RACE), Pakistan Type-2 Diabetes Study, and 1000 Genome Pakistan, andGenetics
of Diabetes and Audit Research Tayside Study(GoDARTS) and GOSHARE. |
| My expertise ranges from basic
pharmacological techniques to the specialization in analysis for disease-gene
association studies and Pharmacogenomics associations in experimental and
observational studies including genome-wide association studies (GWAS), genome
wide association meta-analysis (GWAMA). My major scientific interests center on
identifying genetic architecture of complex human diseases and traits (e.g.
cardiovascular diseases and drug response). My research focus is sources of
inter-patient variability in drug response, particularly cardiovascular drug
pharmacogenomics and disease-gene association that may be relevant to
pharmacogenomics, and the influence of race/ethnicity on drug response and
pharmacogenomics. The majority of my research centers around the
pharmacogenomics of antihypertensive and antidiabetic drugs. |